Stay updated on Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.

Latest updates to the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer now identifies the software revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedAn NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across federal agency content.SummaryDifference0.8%

- Check33 days agoChange DetectedThe website footer revision identifier changed from v3.7.1 to v3.7.2. The study record history content remains unchanged.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site’s displayed software revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history now shows a new revision v3.7.0 added and the previous v3.6.6 removed. This reflects an updated version of the study record in ClinicalTrials.gov.SummaryDifference0.1%

- Check83 days agoChange DetectedThe Record History shows the platform revision updated from v3.6.5 to v3.6.6, replacing the previous version label. This update is a metadata platform release and does not affect study data or visible content.SummaryDifference0.1%

Stay in the know with updates to Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab and Rosuvastatin on Lipid Plaques in CAD Clinical Trial page.